Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JH

John Hey — 16 Patents

ALAlzheon: 9 patents #1 of 7Top 15%
SCSchering: 6 patents #514 of 2,442Top 25%
Merck: 1 patents #5,440 of 9,382Top 60%
Framingham, MA: #103 of 1,271 inventorsTop 9%
Massachusetts: #7,594 of 88,656 inventorsTop 9%
Overall (All Time): #284,196 of 4,157,543Top 7%
16 Patents All Time
John Hey has been granted 16 US patents while listed as an inventor at Alzheon. The first was granted in 1999 and the most recent in April 2025. John Hey ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list John Hey in Framingham, MA, US.

Patents per Year

Patents granted per year, 1999 to 2025Bar chart with a peak of 3 patents in 2021.peak 31999: 1 patents19992001: 1 patents2002: 1 patents20022004: 1 patents2005: 1 patents20052006: 1 patents2013: 1 patents20132019: 1 patents2020: 1 patents20202021: 3 patents2024: 2 patents20242025: 2 patents2025

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12285400 Sulfopropanoic acid derivatives for treating neurodegenerative disorders Petr Kocis, Martin Tolar 2025-04-29
12187668 Compositions and methods for treating and preventing neurodegenerative disorders Petr Kocis, Martin Tolar 2025-01-07
12083082 Methods for treating neurodegenerative disorders Petr Kocis, Martin Tolar, Neil William Flanzraich 2024-09-10
12036208 Methods for treating neurodegenerative disorders Petr Kocis, Martin Tolar 2024-07-16
11191742 Methods of treating neurodegenerative disorders in a particular population Susan Abushakra, Aidan Power, Martin Tolar, Jeremy YU, Petr Kocis 2021-12-07
11077095 Methods for treating neurodegenerative disorders Petr Kocis, Martin Tolar 2021-08-03
11053192 Compositions and methods for treating and preventing neurodegenerative disorders Petr Kocis, Martin Tolar 2021-07-06
10590070 Compositions and methods for treating and preventing neurodegenerative disorders Petr Kocis, Martin Tolar 2020-03-17
10471029 Methods for treating neurological disorders Martin Tolar, Petr Kocis, Jeremy YU 2019-11-12
8524697 C20-C21 substituted glucocorticoid receptor agonists John C. Anthes, Kevin D. McCormick, Robert G. Aslanian, Purakkattle Biju, Michael Y. Berlin +5 more 2013-09-03 $73,082,000
7094784 High affinity ligands for nociceptin receptor ORL-1 Deen Tulshian, Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod +3 more 2006-08-22 $67,032,000
6906081 Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders Robert G. Aslanian 2005-06-14 $160,933,000
6716846 High affinity ligands for nociceptin receptor ORL-1 Deen Tulshian, Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod +3 more 2004-04-06 $155,034,000
6455527 High affinity ligands for nociceptin receptor ORL-1 Deen Tulshian, Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod +3 more 2002-09-24 $283,599,000
6262066 High affinity ligands for nociceptin receptor ORL-1 Deen Tulshian, Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod +3 more 2001-07-17 $82,174,000
5869479 Treatment of upper airway allergic responses William Kreutner 1999-02-09 $265,829,000